Radmila Lyubarova1, William E Boden2, Steven A Fein3, Joshua Schulman-Marcus3, Mikhail Torosoff3. 1. Division of Cardiology, Albany Medical College, 47 New Scotland Avenue, MC44, Albany, NY, 12208, USA. LyubarR@mail.amc.edu. 2. Clinical Trials Network, VA New England Healthcare System, Boston University School of Medicine, Boston, MA, USA. 3. Division of Cardiology, Albany Medical College, 47 New Scotland Avenue, MC44, Albany, NY, 12208, USA.
Abstract
BACKGROUND: Transthoracic echocardiography (TTE) has been used to assess coronary sinus blood flow (CSBF), which reflects total coronary arterial blood flow. Successful angioplasty is expected to improve coronary arterial blood flow. Changes in CSBF after percutaneous coronary intervention (PCI), as assessed by TTE, have not been systematically evaluated. HYPOTHESIS: TTE can be utilized to reflect increased CSBF after a successful, clinically indicated PCI. METHODS: The study cohort included 31 patients (18 females, 62 ± 11 years old) referred for diagnostic cardiac catheterization for suspected coronary artery disease and possible PCI, when clinically indicated. All performed PCIs were successful, with good angiographic outcome. CSBF per cardiac cycle (mL/beat) was measured using transthoracic two-dimensional and Doppler flow imaging as the product of coronary sinus (CS) area and CS flow time-velocity integral. CSBF per minute (mL/min) was calculated as the product of heart rate and CSBF per cardiac cycle. In each patient, CSBF was assessed prospectively, before and after cardiac catheterization with and without clinically indicated PCI. Within- and between-group differences in CSBF before and after PCI were assessed using repeated measures analysis of variance. RESULTS: Technically adequate CSBF measurements were obtained in 24 patients (77%). In patients who did not undergo PCI, there was no significant change in CSBF (278.1 ± 344.1 versus 342.7 ± 248.5, p = 0.36). By contrast, among patients who underwent PCI, CSBF increased significantly (254.3 ± 194.7 versus 618.3 ± 358.5 mL/min, p < 0.01, p-interaction = 0.03). Other hemodynamic and echocardiographic parameters did not change significantly before and after cardiac catheterization in either treatment group. CONCLUSIONS: Transthoracic echocardiographic assessment can be employed to document CSBF changes after angioplasty. Future studies are needed to explore the clinical utility of this noninvasive metric.
BACKGROUND: Transthoracic echocardiography (TTE) has been used to assess coronary sinus blood flow (CSBF), which reflects total coronary arterial blood flow. Successful angioplasty is expected to improve coronary arterial blood flow. Changes in CSBF after percutaneous coronary intervention (PCI), as assessed by TTE, have not been systematically evaluated. HYPOTHESIS: TTE can be utilized to reflect increased CSBF after a successful, clinically indicated PCI. METHODS: The study cohort included 31 patients (18 females, 62 ± 11 years old) referred for diagnostic cardiac catheterization for suspected coronary artery disease and possible PCI, when clinically indicated. All performed PCIs were successful, with good angiographic outcome. CSBF per cardiac cycle (mL/beat) was measured using transthoracic two-dimensional and Doppler flow imaging as the product of coronary sinus (CS) area and CS flow time-velocity integral. CSBF per minute (mL/min) was calculated as the product of heart rate and CSBF per cardiac cycle. In each patient, CSBF was assessed prospectively, before and after cardiac catheterization with and without clinically indicated PCI. Within- and between-group differences in CSBF before and after PCI were assessed using repeated measures analysis of variance. RESULTS: Technically adequate CSBF measurements were obtained in 24 patients (77%). In patients who did not undergo PCI, there was no significant change in CSBF (278.1 ± 344.1 versus 342.7 ± 248.5, p = 0.36). By contrast, among patients who underwent PCI, CSBF increased significantly (254.3 ± 194.7 versus 618.3 ± 358.5 mL/min, p < 0.01, p-interaction = 0.03). Other hemodynamic and echocardiographic parameters did not change significantly before and after cardiac catheterization in either treatment group. CONCLUSIONS: Transthoracic echocardiographic assessment can be employed to document CSBF changes after angioplasty. Future studies are needed to explore the clinical utility of this noninvasive metric.
Authors: Daniel Wing Chong Ng; Konstantinos Vlachonassios; Anoshie R Nimalasuriya; Vu T Nguyen; Charmi Wijesekera; Aameera Khan; P Anthony N Chandraratna Journal: Am J Cardiol Date: 2004-04-01 Impact factor: 2.778
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: I Kronzon; P A Tunick; R Jortner; B Drenger; E S Katz; N Bernstein; L A Chinitz; R S Freedberg Journal: J Am Soc Echocardiogr Date: 1995 Jul-Aug Impact factor: 5.251
Authors: P Siostrzonek; A Kranz; G Heinz; S Rödler; H Gössinger; G Kreiner; A Stümpflen; M Zehetgruber; M Schwarz; H Weber Journal: Am J Cardiol Date: 1993-12-01 Impact factor: 2.778
Authors: M Zehetgruber; G Mundigler; G Christ; D Mörtl; P Probst; H Baumgartner; G Maurer; P Siostrzonek Journal: J Am Coll Cardiol Date: 1995-04 Impact factor: 24.094
Authors: Stefan Verheye; E Marc Jolicœur; Miles W Behan; Thomas Pettersson; Paul Sainsbury; Jonathan Hill; Mathias Vrolix; Pierfrancesco Agostoni; Thomas Engstrom; Marino Labinaz; Ranil de Silva; Marc Schwartz; Nathalie Meyten; Neal G Uren; Serge Doucet; Jean-François Tanguay; Steven Lindsay; Timothy D Henry; Christopher J White; Elazer R Edelman; Shmuel Banai Journal: N Engl J Med Date: 2015-02-05 Impact factor: 91.245
Authors: E Marc Jolicœur; Shmuel Banai; Timothy D Henry; Marc Schwartz; Serge Doucet; Christopher J White; Elazer Edelman; Stefan Verheye Journal: Trials Date: 2013-02-15 Impact factor: 2.279